Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Inventory (2016 - 2025)

Nephros (NEPH) has 16 years of Inventory data on record, last reported at $2.7 million in Q3 2025.

  • For Q3 2025, Inventory fell 11.65% year-over-year to $2.7 million; the TTM value through Sep 2025 reached $2.7 million, down 11.65%, while the annual FY2024 figure was $2.6 million, 5.87% up from the prior year.
  • Inventory reached $2.7 million in Q3 2025 per NEPH's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Inventory topped out at $5.1 million in Q2 2021 and bottomed at $2.0 million in Q1 2025.
  • Average Inventory over 5 years is $3.3 million, with a median of $2.8 million recorded in 2024.
  • Peak YoY movement for Inventory: tumbled 54.42% in 2023, then skyrocketed 36.64% in 2024.
  • A 5-year view of Inventory shows it stood at $4.5 million in 2021, then decreased by 29.34% to $3.2 million in 2022, then dropped by 21.66% to $2.5 million in 2023, then increased by 5.87% to $2.6 million in 2024, then grew by 4.7% to $2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $2.7 million in Q3 2025, $2.2 million in Q2 2025, and $2.0 million in Q1 2025.